AVTX icon

Avalo Therapeutics
AVTX

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $210K invested in Avalo Therapeutics in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$141K
2
+$43.3K
3
+$14.2K
4
FIA
FNY Investment Advisers
New York
+$4K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$986

Top Sellers

1
-$34K
2
-$22K
3
-$19.8K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$16.1K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$11.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$144K
2
$43.3K
3
$16.1K
4
$4K
5
$1K
6
$800
7
$73
8
$18
9
$18
10
$18
11
$9
12
$9
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2